ASH Advances in Cellular Therapy: Tisa-Cel in R/R B-ALL, Blinatumomab Sequencing in ALL, BiTES for DLBCL, Selection/Sequencing of CAR-T vs. BiTE, Brexu-Cel in R/R MCL, BCMA-Targeting in Myeloma

36 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login